These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22732597)

  • 1. Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia.
    Kolditz M; Halank M; Schulte-Hubbert B; Bergmann S; Albrecht S; Höffken G
    Respir Med; 2012 Sep; 106(9):1320-8. PubMed ID: 22732597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae.
    Kontou P; Kuti JL; Nicolau DP
    Am J Emerg Med; 2009 Oct; 27(8):968-74. PubMed ID: 19857416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Serum Albumin and Copeptin with Early Clinical Deterioration and Instability in Community-Acquired Pneumonia.
    Parthasarathi A; Padashetti VC; Padukudru S; Chaya SK; Siddaiah JB; Anand MP
    Adv Respir Med; 2022 Aug; 90(4):323-337. PubMed ID: 36004962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia.
    Phua J; See KC; Chan YH; Widjaja LS; Aung NW; Ngerng WJ; Lim TK
    Thorax; 2009 Jul; 64(7):598-603. PubMed ID: 19386583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care.
    Chalmers JD; Taylor JK; Mandal P; Choudhury G; Singanayagam A; Akram AR; Hill AT
    Clin Infect Dis; 2011 Sep; 53(6):503-11. PubMed ID: 21865188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].
    Christ-Crain M; Morgenthaler NG; Stolz D; Müller C; Bingisser R; Harbarth S; Tamm M; Struck J; Bergmann A; Müller B
    Crit Care; 2006; 10(3):R96. PubMed ID: 16805922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department].
    Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Sicilia-Bravo I; Palomo-de Los Reyes MJ; Cabezas-Martínez A; Laín-Terés N; Estebaran-Martín J; Lozano-Ancín A; Cuena-Boy R
    Enferm Infecc Microbiol Clin; 2014 Apr; 32(4):225-35. PubMed ID: 24182623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.
    Rello J; Rodriguez A; Lisboa T; Gallego M; Lujan M; Wunderink R
    Crit Care Med; 2009 Feb; 37(2):456-62. PubMed ID: 19114916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections.
    Müller B; Morgenthaler N; Stolz D; Schuetz P; Müller C; Bingisser R; Bergmann A; Tamm M; Christ-Crain M
    Eur J Clin Invest; 2007 Feb; 37(2):145-52. PubMed ID: 17217381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.
    Krüger S; Ewig S; Giersdorf S; Hartmann O; Suttorp N; Welte T;
    Am J Respir Crit Care Med; 2010 Dec; 182(11):1426-34. PubMed ID: 20639437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.
    Krüger S; Ewig S; Marre R; Papassotiriou J; Richter K; von Baum H; Suttorp N; Welte T;
    Eur Respir J; 2008 Feb; 31(2):349-55. PubMed ID: 17959641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia.
    Buising KL; Thursky KA; Black JF; MacGregor L; Street AC; Kennedy MP; Brown GV
    Thorax; 2006 May; 61(5):419-24. PubMed ID: 16449258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.
    Courtais C; Kuster N; Dupuy AM; Folschveiller M; Jreige R; Bargnoux AS; Guiot J; Lefebvre S; Cristol JP; Sebbane M
    Am J Emerg Med; 2013 Jan; 31(1):215-21. PubMed ID: 23000327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study.
    Kolditz M; Höffken G; Martus P; Rohde G; Schütte H; Bals R; Suttorp N; Pletz MW;
    BMC Infect Dis; 2012 Apr; 12():90. PubMed ID: 22501026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.
    Krüger S; Ewig S; Kunde J; Hartmann O; Suttorp N; Welte T;
    Thorax; 2010 Mar; 65(3):208-14. PubMed ID: 20335288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin.
    Bello S; Fandos S; Lasierra AB; Mincholé E; Panadero C; Simon AL; Gavin O; De Pablo F; Menendez R; Torres A
    Respir Med; 2015 Sep; 109(9):1193-206. PubMed ID: 26205553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.
    Gordo-Remartínez S; Calderón-Moreno M; Fernández-Herranz J; Castuera-Gil A; Gallego-Alonso-Colmenares M; Puertas-López C; Nuevo-González JA; Sánchez-Sendín D; García-Gámiz M; Sevillano-Fernández JA; Álvarez-Sala LA; Andueza-Lillo JA; de Miguel-Yanes JM
    PLoS One; 2015; 10(6):e0125212. PubMed ID: 26030588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal function is related to prognosis in moderate community-acquired pneumonia.
    Kolditz M; Halank M; Schulte-Hubbert B; Höffken G
    Eur Respir J; 2010 Sep; 36(3):615-21. PubMed ID: 20110392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a clinical prediction model for early admission to the intensive care unit of patients with pneumonia.
    Labarère J; Schuetz P; Renaud B; Claessens YE; Albrich W; Mueller B
    Acad Emerg Med; 2012 Sep; 19(9):993-1003. PubMed ID: 22978725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China.
    Yang Y; Xu F; Shi LY; Diao R; Cheng YS; Chen XY; Jing JY; Wang XD; Shen HH
    Chin Med J (Engl); 2012 Feb; 125(4):639-45. PubMed ID: 22490488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.